BioSpace News Archive

Personalis, Inc. announced that its management team will participate at the following investor conferences: 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference Participating on Monday, August 14, 2023 Sidoti Virtual Micro Cap Conference Presenting on Wednesday, August 16, 2023 at 12:15 p.m. Eastern Time About Personalis, Inc.

Amygdala Neurosciences has been awarded a $2.0 million NIH grant to support the project titled “Investigational New Drug -enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.”

Guardant Health, Inc. announced an agreement with Illumina Inc., a global leader in DNA sequencing and array-based technologies, that resolves their pending litigation and promotes a shared resolution to advance the companies’ long-term, commercial partnership.

Zentalis® Pharmaceuticals, Inc. announced that on August 1, 2023, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 275,000 shares of the Company’s common stock to one newly hired employee.

Prometheus Laboratories Inc. today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser therapeutic drug monitoring (TDM) services for eligible patients receiving the Fresenius Kabi biosimilar, IDACIO (adalimumab-aacf).

Kiyatec, a leading biotechnology company specializing in 3D cell culture technologies, is pleased to announce the appointment of Eric Perreault to the position of President.

SOHM, Inc. announces that the company has signed a letter of intent to acquire stem cell disruptive technology and patents called “ABBIE.”

Psycheceutical Bioscience, Inc. today announced that its auditors RBSM LLP have completed a PCAOB audit of the company’s financial statements for the periods ending December 31, 2022 and 2021.

Zhejiang Innoforce Pharmaceuticals Co., Ltd., a CDMO company dedicated to providing one-stop-shop services to Advanced Therapy Medicinal Product customers and partners, announced Dr. Dewan Zeng as the new Chief Executive Officer, effective immediately.

Acutus Medical, Inc. granted equity awards on August 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in July 2023.